 |
RETHINK your approach to allergy immunotherapy. RESPIT (regionally-specific immunotherapy) extracts are standardized to include the most important allergens in your geographic area. This approach has been found to be effective for approximately 75% of dogs with atopic dermatitis with subcutaneous administration. Avoid the variability associated with allergy testing and the subjectivity of immunotherapy formulation by prescribing RESPIT. Pet owners appreciate this common sense approach.
RESPIT Oromucosal Spray delivers concentrated allergens to the mucosal immune system with an easy-to-use device, designed for infants. Some pets and their owners find that administering a daily oral spray between the cheek and gums is more pleasant than giving weekly subcutaneous injections.
This form of immunotherapy, known as SLIT (sublingual immunotherapy), has become the most common route of administration for humans in many countries because:
- serious side effects are very uncommon
- it is as effective as injectable immunotherapy
- a build-up phase is not required
- patients sometimes respond more quickly
Studies in dogs at the University of Florida and the University of Wisconsin have found that oral immunotherapy is well tolerated and results in significant improvement in 60-70% of those treated. RESPIT Oromucosal Sprays contain the same 20 ingredients as their RESPIT Injectable counterparts, plus the molds Alternaria and Cladosporium.
|
|
|
